JHIU
AVNR

Janus Henderson Investors US’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Janus Henderson Investors US’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-52,739
Closed -$629K – 1160
2014
Q3 		$629K Buy
+52,739
New +$360K ﹤0.01% 1000

Other funds holding AVNR

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Janus Henderson Investors US's AVNR Position: Q4 2014 in Review

Janus Henderson Investors US sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014, closing a stake of 52,739 shares — an estimated $629K sold.

Janus Henderson Investors US first reported a position in AVNR in Q3 2014 and held it in 1 quarter. The position peaked at $629K in Q3 2014. 166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

  • Janus Henderson Investors US reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q4 2014 after selling out during the quarter.
  • Janus Henderson Investors US sold 52,739 AVANIR PHARMACEUTICALS, INC CL A shares in Q4 2014, an estimated $629K.
  • Janus Henderson Investors US first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2014 and held it in 1 quarter.
  • Janus Henderson Investors US's AVANIR PHARMACEUTICALS, INC CL A position peaked at $629K in Q3 2014.
  • 166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Janus Henderson Investors US's 13F filing for Q4 2014, filed 18 Feb 2015.